These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10657536)

  • 1. Structure-activity analysis of N-acetyl [Leu(28,31)] NPY 24-36: a potent neuropeptide Y Y(2) receptor agonist.
    Smith-White MA; Potter EK
    Neuropeptides; 1999 Dec; 33(6):526-33. PubMed ID: 10657536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
    Fournier A; Gagnon D; Quirion R; Cadieux A; Dumont Y; Pheng LH; St-Pierre S
    Mol Pharmacol; 1994 Jan; 45(1):93-101. PubMed ID: 8302286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
    Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
    J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of prejunctional receptor binding analog of human neuropeptide Y dimer ANA-NPY.
    Barden JA
    Biochem Biophys Res Commun; 1995 Oct; 215(1):264-71. PubMed ID: 7575600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of helical potential to the in vitro receptor binding activity of a neuropeptide Y N-terminal deletion fragment.
    Doughty MB; Hu L
    Biopolymers; 1993 Aug; 33(8):1195-206. PubMed ID: 8364154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of alpha-helix in C-terminal fragments of neuropeptide Y.
    Yumoto N; Murase S; Hattori T; Yamamoto H; Tatsu Y; Yoshikawa S
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1490-5. PubMed ID: 8250906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission.
    Smith-White MA; Herzog H; Potter EK
    Regul Pept; 2002 Feb; 103(2-3):105-11. PubMed ID: 11786149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
    J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
    Lerch M; Mayrhofer M; Zerbe O
    J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-helical small molecular size analogues of neuropeptide Y: structure-activity relationships.
    Jung G; Beck-Sickinger AG; Dürr H; Gaida W; Schnorrenberg G
    Biopolymers; 1991 May; 31(6):613-9. PubMed ID: 1657233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
    J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs.
    Mahns DA; Lacroix JS; Potter EK
    J Auton Nerv Syst; 1998 Nov; 73(2-3):80-5. PubMed ID: 9862381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of neuropeptide Y(2) receptors exerts an excitatory action on cardio-respiratory variables in anaesthetized rats.
    Kaczyńska K; Szereda-Przestaszewska M
    Neuropeptides; 2011 Aug; 45(4):281-6. PubMed ID: 21658765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats.
    Silva AP; Xapelli S; Pinheiro PS; Ferreira R; Lourenço J; Cristóvão A; Grouzmann E; Cavadas C; Oliveira CR; Malva JO
    J Neurochem; 2005 Apr; 93(1):163-70. PubMed ID: 15773916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
    Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
    Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac function in neuropeptide Y Y4 receptor-knockout mice.
    Smith-White MA; Herzog H; Potter EK
    Regul Pept; 2002 Dec; 110(1):47-54. PubMed ID: 12468109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y inhibits [Ca2+]i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors.
    Alvaro AR; Rosmaninho-Salgado J; Ambrósio AF; Cavadas C
    J Neurochem; 2009 Jun; 109(5):1508-15. PubMed ID: 19344373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
    Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
    Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.